Riskpilot← Back to searchSign inGet full accessSpecsavers Borås AB
ABActiveOrg 5569865529Österlånggatan 45Retail sale of medical and orthopaedic goods · NACE 4774Est. 201414 employees
Revenue 2025
SEK 21,1M
+11% vs 2024
EBITDA margin
3.9%
+1032% vs 2024
Equity ratio
21.2%
Financial strength
Net profit 2025
SEK 553K
+501% vs 2024
| Revenue | SEK 21,1M | +11% |
| EBITDA | SEK 815K | +1032% |
| Net profit | SEK 553K | +501% |
| Total assets | SEK 4,8M | +9% |
| Equity | SEK 1M | +117% |
| Employees | 14 | — |
Legal name
Specsavers Borås AB
Org number
5569865529
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
15 oktober 2014
Share capital
SEK 50 000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Bertilson, Marita Carola Louise Genckel Schmidt, Pernille Owens, Richard Neil Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva detaljhandelsrörelse inom optikområdet samt bedriva därmed förenlig verksamhet.
Address
Österlånggatan 45
Phone
+46317719800
Email
fas@specsavers.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 11 435 | 13 041 | 15 835 | 13 451 | 17 580 | 20 026 | 19 015 | 21 092 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 764 | 897 | 736 | 510 | 878 | 843 | 915 | 1 003 | 72 | 815 |
| Depreciation & amort. | −103 | −161 | −186 | −326 | −526 | −363 | −343 | −392 | −210 | −125 |
| EBIT | 661 | 736 | 550 | 184 | 352 | 480 | 572 | 611 | −138 | 690 |
| Net financials | — | −45 | −34 | −31 | −16 | −5 | −2 | — | — | 6 |
| Profit before tax | 662 | 692 | 516 | 153 | 336 | 475 | 570 | 271 | −138 | 696 |
| Tax | −147 | −162 | −115 | −47 | −75 | −105 | −122 | −64 | −0 | −143 |
| Net profit | 515 | 530 | 401 | 106 | 261 | 370 | 448 | 207 | −138 | 553 |
| Item | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 759 | 3 756 | 3 594 | 3 654 | 3 737 | 3 969 | 5 137 | 5 118 | 4 449 | 4 841 |
| Equity | 565 | 1 094 | 750 | 856 | 611 | 981 | 799 | 557 | 472 | 1 025 |
| Long-term debt | 843 | 679 | 294 | 161 | 79 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 351 | 1 983 | 2 550 | 2 637 | 3 046 | 2 988 | 4 338 | 4 561 | 3 977 | 3 815 |
| Total debt | 3 194 | 2 662 | 2 844 | 2 798 | 3 125 | 2 988 | 4 338 | 4 561 | 3 977 | 3 815 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20152025
Equity ratio
21.2%
This company
38.2%
Market median
-45% vs market
20152025
Return on equity
54.0%
This company
18.4%
Market median
+193% vs market
20152025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20152025
Asset turnover
4.36×
This company
1.12×
Market median
+289% vs market
20152025
Debt / equity
3.72×
This company
0.62×
Market median
-500% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-01-01 – 2020-02-29
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-10-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LR Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
SM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 | — | — |
PG External Signatory | External Signatory | 2024 | — | — |
AC Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Borås Specsavers Optic Services AB | Company | 99.0% | 99.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
100 % Rosa AB
Specsavers Borås AB Board members of Specsavers Borås AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Robert Blomquist | Chief Executive Officer | 0 companies |
| Sammi Monir Haji | Deputy Chief Executive Officer | 0 companies |
| Pernille Genckel Schmidt | External Signatory | 0 companies |
| Anna Cecilia Grimslätt | Chief Auditor | 0 companies |
| Nigel David Parker | Chairman | 0 companies |
| Richard Neil Owens | Chairman | 0 companies |
| Marita Carola Louise Bertilson | Board of Directors | 0 companies |